詳細

 

英文著書 | 英文論文 | 和文論文

 

ウイルス第一部　発表論文（2020年）

 

英文著書
  1. Andoh M, Gokuden M, Honda T, Fujita H, Yamamoto S, Kadosaka T, Takano A, Yano Y, Takada N, Kawabata H Ando S. Chapter 15 Surveillance of Tsutsugamushi Disease and Acari-borne Diseases in the Tokara Islands. The Tokara Islands (ed. Otsuka Y, Terada R, NishimuraS), pp136-141, March 2020
  2. Smith IL, Demetria C, Fukushi S. Reston Ebolavirus in Macaques. S. Knauf, L. Jones-Engel (eds.), Neglected Diseases in Monkeys, Springer Nature Switzerland AG2020. pp275-289, 2020

 

 

英文論文
  1. Akagi K, Miyazaki T, Oshima K, Umemura A, Shimada S, Morita K, Senju H, Tashiro M, Takazono T, Saijo T, Kurihara S, Sekino M, Yamamoto K, Imamura Y, Izumikawa K, Yanagihara K, Uda A, Morikawa S, Yoshikawa T, Kurosu T, Shimojima M, Saijo M, Mukae H. Detection of viral RNA in diverse body fluids in an SFTS patient with encephalopathy, gastrointestinal bleeding and pneumonia: a case report and literature review. BMC Infect Dis. 20(1):281, 2020. doi: 10.1186/s12879-020-05012-8.
  2. Aonuma H, Iizuka-Shiota I, Hoshina T, Tajima S, Kato F, Hori S, Saijo M, Kanuka H. Detection and discrimination of multiple strains of Zika virus by reverse transcription-loop-mediated isothermal amplification. Trop Med Health. 48:87, 2020. doi: 10.1186/s41182-020-00274-z.
  3. Doi Y, Hibino M, Hase R, Yamamoto M, Kasamatsu Y, Hirose M, Mutoh Y, Homma Y, Terada M, Ogawa T, Kashizaki F, Yokoyama T, Koba H, Kasahara H, Yokota K, Kato H, Yoshida J, Kita T, Kato Y, Kamio T, Kodama N, Uchida Y, Ikeda N, Shinoda M, Nakagawa A, Nakatsumi H, Horiguchi T, Iwata M, Matsuyama A, Banno S, Koseki T, Teramachi M, Miyata M, Tajima S, Maeki T, Nakayama E, Taniguchi S, Lim CK, Saijo M, Imai T, Yoshida H, Kabata D, Shintani A, Yuzawa Y, Kondo M. A Prospective, randomized, open-label trial of early versus late favipiravir therapy in hospitalized patients with COVID-19. Antimicrob Agents Chemother. 64(12):e01897-20, 2020. doi: 10.1128/AAC.01897-20.
  4. Fukushi S. Competitive ELISA for the Detection of serum antibodies specific for Middle East respiratory syndrome coronavirus (MERS-CoV). Methods Mol Biol. 2203:55-65, 2020.
  5. Griksheit K, Dolnik O, Takamatsu Y, Pereia RA, Becker S. Ebola Virus Nucleocapsid-Like Structures Utilize Arp2/3 Signaling for Intracellular Long-Distance Transport. Cells. 9(7):1728, 2020. doi: 10.3390/cells9071728.
  6. Hamaguchi M, Suzuki K, Fujita H, Uzuka T, Matsuda H, Shishido-Hara Y, Arai S, Nakamura T, Kikuchi S, Nakamichi K, Saijo M, Hirata K. Successful treatment of non-HIV progressive multifocal leukoencephalopathy: case report and literature review. J Neurol. 267(3):731-738, 2020. doi: 10.1007/s00415-019-09629-x.
  7. Harada T, Fukushi S, Kurosu T, Yoshikawa T, Shimojima M, Tanabayashi K, Saijo M. 2020 Mar. Inactivation of severe fever with thrombocytopenia syndrome virus for improved laboratory safety. J Biosafety Biosecurity 2:31-35, 2020
  8. Hazlewood JE, Rawle DJ, Tang B, Yan K, Vet LJ, Nakayama E, Hobson-Peters J, Hall RA, Suhrbier A. A Zika vaccine generated using the chimeric insect-specific Binjari virus platform protects against fetal brain infection in pregnant mice. Vaccines (Basel). 8(3):496, 2020. doi: 10.3390/vaccines8030496.
  9. Harada S, Saijo M. Conditional expression of a dominant-negative form of Epstein-Barr virus (EBV) nuclear antigen EBNALP inhibits EBV-positive lymphoblastoid cell growth. Arch Virol. 165:313-320, 2020. doi: 10.1007/s00705-019-04489-2.
  10. Harada T, Fukushi S, Kurosu T, Yoshikawa T, Shimojima M, Tanabayashi K, Saijo M. Inactivation of severe fever with thrombocytopenia syndrome virus for improved laboratory safety. J Biosafety Biosecurity. 2:31-35, 2020.
  11. Inagaki T, Yamada S, Fujii H, Yoshikawa T, Shibamura M, Harada S, Fukushi S, Le MQ, Nguyen CT, Nguyen TTT, Nguyen TT, Nguyen TT, Quach VT, Thong VD, Mori K, Sasaki M, Setiyono A, Handharyani E, Takeyama H, Hasebe F, Saijo M. Characterization of a novel alphaherpesvirus isolated from the fruit bat Pteropus lylei in Vietnam. J Virol. 94(18):e00673-20, 2020.
  12. Kato H, Satoh M, Kawahara M, Kitaura S, Yoshikawa T, Fukushi S, Dimitrova K, Wood H, Saijo M, Takayama-Ito M. Seroprevalence of Jamestown Canyon virus in the Japanese general population. BMC Infect Dis. 20(1):790, 2020. doi: 10.1186/s12879-020-05517-2.
  13. Katsuse K, Akiyama K, Ishida T, Kitayama C, Ishibashi Y, Ochi M, Kumasaka T, Takahashi K, Suzuki T, Nakamichi K, Saijo M, Hashida H. Progressive multifocal leukoencephalopathy in a patient with primary amyloid light-chain amyloidosis. Clin Neurol Neurosurg. 192:105709, 2020. doi: 10.1016/j.clineuro.2020.105709.
  14. Kobayashi Y, Kato H, Yamagishi T, Shimada T, Matsui T, Yoshikawa T, Kurosu T, Shimojima M, Morikawa S, Hasegawa H, Saijo M, Oishi K; SFTS Epidemiological Research Group Japan. Severe fever with thrombocytopenia syndrome, Japan, 2013-2017. Emerg Infect Dis. 26(4):692-699, 2020. doi: 10.3201/eid2604.191011.
  15. Kozuki E, Arima Y, Matsui T, Sanada Y, Ando S, Sunagawa T, Oishi K. Human psittacosis in Japan: notification trends and differences in infection source and age distribution by gender, 2007 to 2016. Ann Epidemiol. 44: 60-63, 2020. doi: 10.1016/j.annepidem.2020.03.001.
  16. Matsuyama S, Kawase M, Nao N, Shirato K, Ujike M, Kamitani W, Shimojima M, Fukushi S. The inhaled steroid ciclesonide blocks SARS-CoV-2 RNA replication by targeting the viral replication-transcription complex in cultured cells. J Virol. 2020 Oct 14:JVI.01648-20. doi: 10.1128/JVI.01648-20.
  17. Murakami S, Kitamura T, Suzuki J, Sato R, Aoi T, Fujii M, Matsugo H, Kamiki H, Ishida H, Takenaka-Uema A, Shimojima M, Horimoto T. Detection and Characterization of Bat Sarbecovirus Phylogenetically Related to SARS-CoV-2, Japan. Emerg Infect Dis. 26(12):3025-3029, 2020. doi: 10.3201/eid2612.203386.
  18. Nakayama K, Nakamura M, Konishi A, Kaneko S, Nakamichi K, Saijo M, Yakushiji Y, Kusaka H. JC virus granule cell neuronopathy associated with Ruxolitinib: A case report and review of the literature. eNeurologicalSci. 21:100269, 2020. doi: 10.1016/j.ensci.2020.100269.
  19. Nishimura K, Iwai Y, Yabuki M, Fuse H, Nakamichi K, Takahashi K, Suzuki T, Saijo M, Fukushima T, Kuwabara S. Lenalidomide‐associated progressive multifocal leukoencephalopathy. Clin Exp Neuroimmunol. 12:63-65, 2021. doi: 10.1111/cen3.12606.
  20. Nguyen W, Nakayama E, Yan K, Tang B, Le TT, Liu L, Cooper TH, Hayball JD, Faddy HM, Warrilow D, Allcock RJN, Hobson-Peters J, Hall RA, Rawle DJ, Lutzky VP, Young P, Oliveira NM, Hartel G, Howley PM, Prow NA, Suhrbier A. Arthritogenic alphavirus vaccines: Serogrouping versus cross-protection in mouse models. Vaccines (Basel). 8(2):209, 2020. doi: 10.3390/vaccines8020209.
  21. Nguyen PHA, Yamada S, Shibamura M, Inagaki T, Fujii H, Harada S, Fukushi S, Mizuguchi M, Saijo M. New mechanism of acyclovir resistance of herpes simplex virus 1, which has an amber UAG codon between the first and second AUG initiation codons. Jpn J Infect Dis. 2020; Nov 24;73(6):447-451
  22. Noguchi K, Majima R, Takahashi K, Iwase Y, Yamada S, Satoh K, Koshizuka T, Inoue N Identification and functional analyses of a cell-death inhibitor encoded by guinea pig cytomegalovirus gp38.1 in cell culture and in animals. J Gen Virol. 2020;101(12):1270-1279. doi: 10.1099/jgv.0.001493.
  23. Kurosu T, Hanabara K, Asai A, Pambudi S, Phanthanawiboon S, Omokoko MD, Ono KI, Saijo M, Ramasoota P, Ikuta K. Chimeric flavivirus enables evaluation of antibodies against dengue virus envelope protein in vitro and in vivo. Sci Rep. 10(1):21561, 2020. doi: 10.1038/s41598-020-78639-x.
  24. Ogawa M, Shirasago Y, Tanida I, Kakuta S, Uchiyama Y, Shimojima M, Hanada K, Saijo M, Fukasawa M. Structural basis of antiviral activity of caffeic acid against severe fever with thrombocytopenia syndrome virus. J Infect Chemother. 2020 Oct 24:S1341-321X(20)30374-3. doi: 10.1016/j.jiac.2020.10.015.
  25. Ogawa M, Shimojima M, Saijo M, Fukasawa M. Several catechins and flavonols from green tea inhibit severe fever with thrombocytopenia syndrome virus infection in vitro. J Infect Chemother. 27(1):32-39, 2021. doi: 10.1016/j.jiac.2020.08.005.
  26. Ogawa M, Ando S, Saijo M. Evaluation of recombinant type-specific antigens of Orientia tsutsugamushi expressed by a baculovirus-insect cell system as antigens for indirect immunofluorescence assay in the serological diagnosis of Scrub typhus. Jpn J Infect Dis. 73(5): 330-335, 2020.
  27. Oluwayelu D, Afrough B, Adebiyi A, Varghese A, Eun-Sil P, Fukushi S, Yoshikawa T, Saijo M, Neumann E, Morikawa S, Hewson R, Tomori O. Prevalence of Antibodies to Crimean-Congo Hemorrhagic Fever Virus in Ruminants, Nigeria, 2015. Emerg Infect Dis. 26(4):744-747, 2020.
  28. Peng SH, Yang SL, Tang SE, Wang TC, Hsu TC, Su CL, Chen MY, Shimojima M, Yoshikawa T, Shu PY. Human case of severe fever with thrombocytopenia syndrome virus infection, Taiwan, 2019. Emerg Infect Dis. 26(7):1612-1614, 2020. doi: 10.3201/eid2607.200104.
  29. Sajiki Y, Konnai S, Ochi A, Okagawa T, Githaka N, Isezaki M, Yamada S, Ito T, Ando S, Kawabata H, Da Silva Vaz Jr I, Logullo C, Murata S, Ohashi K. Immunosuppressive effects of sialostatin L1 and L2 isolated from the taiga tick Ixodes persulcatus Schulze.　Ticks Tick Borne Dis. 11(2):101332, 2020. doi: 10.1016/j.ttbdis.2019.101332.
  30. Sekimukai H, Iwata-Yoshikawa N, Fukushi S, Tani H, Kataoka M, Suzuki T, Hasegawa H, Niikura K, Arai K, Nagata N. Gold nanoparticle-adjuvanted S protein induces a strong antigen-specific IgG response against severe acute respiratory syndrome-related coronavirus infection, but fails to induce protective antibodies and limit eosinophilic infiltration in lungs. Microbiol Immunol. 64(1):33-51, 2020
  31. Shibamura M, Yoshikawa T, Yamada S, Inagaki T, Nguyen PHA, Fujii H, Harada S, Fukushi S, Oka A, Mizuguchi M, Saijo M. Association of human cytomegalovirus (HCMV) neutralizing antibodies with antibodies to the HCMV glycoprotein complexes. Virol J. 17(1):120, 2020. doi: 10.1186/s12985-020-01390-2.
  32. Shimojima M, Sugimoto S, Taniguchi S, Yoshikawa T, Kurosu T, Saijo M. Efficient functional screening of a cellular cDNA library to identify severe fever with thrombocytopenia syndrome virus entry factors. Sci Rep. 10(1):5996, 2020. doi: 10.1038/s41598-020-62876-1.
  33. Su H, Onoda E, Tai H, Fujita H, Sakabe S, Azuma K, Akachi S, Oishi S, Abe F, Ando S, Ohashi N. Diversity unearthed by the estimated molecular phylogeny and ecologically quantitative characteristics of uncultured Ehrlichia bacteria in Haemaphysalis ticks, Japan. Sci Rep. 1(1):687, 2021. doi: 10.1038/s41598-020-80690-7.
  34. Sugimoto S, Suda Y, Yoshikawa T, Kurosu T, Mizutani T, Saijo M, Shimojima M. Terminal Genome Sequences of the Soft Tick Bunyavirus. Microbiol Resour Announc. 9(18):e00126-20, 2020. doi: 10.1128/MRA.00126-20.
  35. Suzuki T, Sato Y, Sano K, Arashiro T, Katano H, Nakajima N, Shimojima M, Kataoka M, Takahashi K, Wada Y, Morikawa S, Fukushi S, Yoshikawa T, Saijo M, *Hasegawa H. Severe fever with thrombocytopenia syndrome virus targets B cells in lethal human infections. J Clin Invest. 130(2):799-812, 2020. doi: 10.1172/JCI129171.
  36. Tachida Y, Kumagai K, Sakai S, Ando S, Yamaji T, Hanada K. Chlamydia trachomatis-infected human cells convert ceramide to sphingomyelin without sphingomyelin synthase 1 and 2. FEBS Letter, 594: 519-529. 2020. doi: 10.1002/1873-3468.13632.
  37. Takamatsu Y, Kolesnikova L, Schauflinger M, Noda T, Becker S. The integrity of the YxxL motif of Ebola virus VP24 is important for the transport of nucleocapsid-like structures and for the regulation of viral RNA synthesis. J.Virol. 2020, 94(9), doi:10.1128/JVI.02170-19.
  38. Takamatsu Y, Kr?hling V, Kolesnikova L, Halwe S, Lier C, Baumeister S, Noda T, Biedenkopf N, Becker S. Serine-arginine protein kinase 1 regulates ebola virus transcription. mBio 11(1):e02565-19 -, 2020. doi:10.1128/mBio.02565-19.
  39. Takayama-Ito M, Saijo M. Antiviral drugs against severe fever with thrombocytopenia syndrome virus infection. Front Microbiol. 11:150, 2020. doi: 10.3389/fmicb.2020.00150.
  40. Tajima S, Taniguchi S, Nakayama E, Maeki T, Inagaki T, Lim CK, Saijo M. Amino acid at position 166 of NS2A in Japanese encephalitis virus (JEV) is associated with in vitro growth characteristics of JEV. Viruses. 12(7):709, 2020. doi: 10.3390/v12070709.
  41. Tani H, Kimura M, Yamada H, Fujii H, Taniguchi S, Shimojima M, Fukushi S, Morikawa S, Saijo M. Activation of platelet-derived growth factor receptor beta in the severe fever with thrombocytopenia syndrome virus infection. Antiviral Res. 182:104926, 2020. doi: 10.1016/j.antiviral.2020.104926.
  42. Taniguchi S, Yoshikawa T, Shimojima M, Fukushi S, Kurosu T, Tani H, Fukuma A, Kato F, Nakayama E, Maeki T, Tajima S, Lim CK, Ebihara H, Kyuwa S, Morikawa S, Saijo M. Analysis of the function of the lymphocytic choriomeningitis virus S segment untranslated region on growth capacity in vitro and on virulence in vivo. Viruses. 16;12(8):896, 2020. doi: 10.3390/v12080896.
  43. Ueno H, Kikumto M, Takebayashi Y, Ishibashi H, Takahashi T, Yasutomi H, Umemoto K, Nakamichi K, Saijo M, Ichinohe T, Maruyama H. Pomalidomide-associated progressive multifocal leukoencephalopathy in multiple myeloma: cortical susceptibility-weighted imaging hypointense findings prior to clinical deterioration. J Neurovirol. 26(3):452-455, 2020. doi: 10.1007/s13365-020-00845-0.
  44. Umeki K, Yasuda A, Umekita K, Megumi R, Nomura H, Kawaguchi T, Matsuda M, Takajo I, Shimojima M, Okayama A. Detection of anti-SFTSV nuclear protein antibody in the acute phase sera of patients using double-antigen ELISA and immunochromatography. J Virol Methods. 285:113942, 2020. doi: 10.1016/j.jviromet.2020.113942.
  45. Usui Y, Nakano H, Komatsu J, Nakamichi K, Saijo M, Takano S, Kamiya KI, Hamaguchi T, Yamada M. Progressive multifocal leukoencephalopathy during treatment with lenalidomide and elotuzumab for multiple myeloma. Leuk Lymphoma. 61(9):2234-2237, 2020. doi: 10.1080/10428194.2020.1765237.
  46. Watanabe M, Arii J, Takeshima K, Fukui A, Shimojima M, Kozuka-Hata H, Oyama M, Minamitani T, Yasui T, Kubota Y, Takekawa M, Kosugi I, Maruzuru Y, Koyanagi N, Kato A, Mori Y, Kawaguchi Y. Prohibitin-1 contributes to the cell-to-cell transmission of herpes simplex virus 1. J Virol. 95(3):e01413-20, 2020. doi: 10.1128/JVI.01413-20.
  47. Watanabe S, Fukushi S, Harada T, Shimojima M, Yoshikawa T, Kurosu T, Kaku Y, Morikawa S, Saijo M. Effective inactivation of Nipah virus in serum samples for safe processing in low-containment laboratories. Virol J. 17(1):151, 2020. doi: 10.1186/s12985-020-01425-8.

 

 

和文論文
  1. 伊藤（高山）睦代，西條政幸. 狂犬病. Clinical Neuroscience. 38:1275-1277, 2020.
  2. 山田壮一, 福士秀悦, 西條政幸. 突発性発疹のウイルス学的な検査法IASR41:214-215, 2020.
  3. 安藤秀二．リケッチア感染症診断マニュアル（令和元年6月版）の概要．IASR 41(8)：141，2020.
  4. 藤田博己，安藤秀二．日本紅斑熱リケッチア媒介マダニの国内分布状況．病原体微生物検出情報，41(8)：138-139，2020年.
  5. 新倉(座本)綾，佐藤雅彦，川端寛樹，大久保（佐藤）梢，安藤秀二，石原智明，花木賢一．利尻島におけるマダニ相と保有病原体の調査，利尻研究 Rishiri Studies 39: 41-46, 2020.
  6. 安藤秀二．つつが虫病・日本紅斑熱．日本獣医師会雑誌　73: 6-12, 2020.
  7. 島田瑞穂，川端寛樹，安藤秀二，彭志中，小林由美江，廣瀬芳江，周藤史憲，清水和彦，高橋孝行，小松本悟．栃木県足利赤十字病院における3年間（2017～2019年）のマダニ刺症72例の検討－タカサゴキララマダニ刺症62例を中心に－．衛生動物　71(3): 219-223，2020.
  8. 山田壮一，福士秀悦，西條政幸．突発性発疹のウイルス学的な検査法．IASR 41:214-215, 2020.
  9. 中山絵里，前木孝洋，谷口怜，田島茂，林昌宏，西條政幸．デング熱の流行状況．IASR 41: 93-94, 2020.
  10. 西村光司，金澤剛二，森岡一朗，林昌宏，田島茂，前木孝洋，中山絵里，谷口怜，西條政幸．5年ぶりに確認された日本国内で感染したデング熱の3例．IASR 41:94-96, 2020.
  11. 西條政幸．最近の重症熱性血小板減少症候群（SFTS）の動向．バムサジャーナル 32:11-14, 2020
  12. 田島茂，中山絵里，前木孝洋，谷口怜，林昌宏，西條政幸．2014年に国内感染例として発表されている, 兵庫県西宮市でのデングウイルス1型によるデング熱患者について．IASR 41:97-99, 2020.
  13. 前木孝洋，中山絵里，谷口怜，田島茂，林昌宏，西條政幸．デング熱ワクチンの現状と展望．IASR 41:99-100, 2020.
  14. 児玉文宏，枝川峻二，永坂敦，松野啓太，好井健太朗，澤洋文，山岸彩沙，古澤弥，山口亮，矢野公一，山口宏樹，後藤明子，駒込理佳，三好正浩，伊東拓也，小山内佑太，角千春，堀田明豊，前田健，安藤秀二，西條政幸．北海道における新規オルソナイロウイルス（エゾウイルス:Yezo virus）によるマダニ媒介性急性発熱性疾患の発見．IASR 41:11-13, 2020.
  15. 西條政幸．私たちは数百年に一度の人間社会に大きな影響をおよぼすウイルス感染症流行のなかにいる-動物由来のウイルスとしての特徴とワクチン開発への期待．科学（岩波書店） 90(6):512-517, 2020.
  16. 西條政幸．一人の免疫不全患者から学ぶウイルス感染症学：薬剤耐性単純ヘルペスウイルス1型感染症．Neuroinfection 25:1-6, 2020.
  17. 西條政幸．最近の重症熱性血小板減少症候群（SFTS）の動向．バムサジャーナル 32:11-14, 2020.
  18. 西條政幸．災害医療2020 - 大規模イベント，テロ対応を含めて．サーベイランスの強化（感染症対策）日本医師会雑誌 149（増刊号）:244-255, 2020.
  19. 北崎佑樹，岩﨑博道，北井隆平，高橋健太，中道一生，濱野 忠則．脳脊髄液中のJCV-DNA遺伝子検査が2回とも陰性であったが，開頭脳生検で診断確定したHIV関連進行性多巣性白質脳症の1例．BRAIN and NERVE 72(5):541-546, 2020
  20. 安藤秀二．つつが虫病・日本紅斑熱．日本獣医師会雑誌　73:6-12, 2020

 

Copyright 1998 National Institute of Infectious Diseases, Japan